Subject: Re: IV and growth estimates
How are people reflecting OxyChem in their IV estimates? $9.5B went out the door to buy it. The add-back is....

The 10-Q notes that OxyChem had a small loss during Q1 which was mainly due to deal related costs.

I am adding back $9.5B for the time being which is probably a little low. Presumably BRK thought we were getting at least that much in value.